How a Diabetes Drug Might Help Protect Cartilage
Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
A diabetes drug directly protects cartilage cells from sugar-induced damage by turning down RAGE, a key inflammation trigger.
RAGE was thought to be mainly involved in diabetes complications like nerve and kidney damage — not joint disease. Linking GLP-1 drugs to RAGE suppression in cartilage is a novel mechanism.
Practical Takeaways
If you have diabetes or prediabetes and joint pain, talk to your doctor about whether a GLP-1 drug might offer dual benefits.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
A diabetes drug directly protects cartilage cells from sugar-induced damage by turning down RAGE, a key inflammation trigger.
RAGE was thought to be mainly involved in diabetes complications like nerve and kidney damage — not joint disease. Linking GLP-1 drugs to RAGE suppression in cartilage is a novel mechanism.
Practical Takeaways
If you have diabetes or prediabetes and joint pain, talk to your doctor about whether a GLP-1 drug might offer dual benefits.
Publication
Journal
BMC Musculoskeletal Disorders
Year
2024
Authors
Xianyu Zhang, Jian Jiang, Jiajia Xu, Jian Chen, YunTao Gu, Guobao Wu
Related Content
Claims (6)
A type of peptide used in diabetes and weight-loss drugs might help calm inflammation in joint cells.
In rat cartilage cells exposed to harmful sugar byproducts, a diabetes drug called liraglutide seems to lower the levels of a key receptor involved in inflammation, which might help protect the cells.
When rat cartilage cells are stressed by sugar-related toxins, the diabetes drug liraglutide seems to calm down inflammation — suggesting it might help protect joints in conditions like diabetes.
In stressed cartilage cells from rats, the diabetes drug liraglutide seems to lower the activity of harmful enzymes that break down cartilage, which might help protect joints when the body is under metabolic stress.
In stressed cartilage cells from rats, the diabetes drug liraglutide seems to help keep important structural proteins in place, which might protect the cartilage from damage.